Description
The marker is associated with changes in methionine metabolism. It is used to detect genetic predisposition to hyperhomocysteinemia, neonatal homocystinuria and hypomethioninemia, neurological disorders of fetal development, developmental delay and seizures, and for calculating prognoses in carcinogenesis. OMIM: 156570.
Period of execution
Within 6 days. The specified time does not include the day of biomaterial collection
Biomaterial type
- Buccal (cheek) epithelium
- Venous blood